science
plus
.abes.fr
|
explorer
À propos de :
http://hub.abes.fr/oup/periodical/jac/1998/volume_42/issue_3/w
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
bibo:Issue
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
work
Issue
New Facet based on Instances of this Class
Attributs
Valeurs
type
work
Issue
Is Part Of
http://hub.abes.fr/oup/periodical/jac/1998/volume_42
has manifestation of work
http://hub.abes.fr/oup/periodical/jac/1998/volume_42/issue_3/m/print
http://hub.abes.fr/oup/periodical/jac/1998/volume_42/issue_3/m/web
issue
3
is
Is Part Of
of
Study of the combination of ranitidine bismuth citrate and metronidazole against metronidazole-resistant Helicobacter pylori clinical isolates.
In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.
In-vitro activity of N,N-dimethyl-2-propen-1-amines against Mycobacterium tuberculosis.
Trends in antimicrobial resistance of Streptococcus pneumoniae in children in a Turkish hospital.
Ciprofloxacin prophylaxis and therapy of Yersinia pestis infection.
Safety, tolerability and pharmacokinetics of the new long-acting quinolone DW-116 after single and multiple dosing in healthy subjects.
Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience.
The detection of penicillin insensitivity in Neisseria meningitidis by polymerase chain reaction.
Intermediate vancomycin resistance in Staphylococcus aureus: a major threat or a minor inconvenience?
New guidelines for the antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis.
Comparative in-vitro activities of amoxycillin and penicillin against Streptococcus pneumoniae isolates.
The in-vitro activities of co-amoxiclav and other oral antibiotics against Streptococcus pneumoniae isolates exhibiting intermediate susceptibility to penicillin.
An LY333328-dependent strain of Enterococcus faecalis isolated from a blood culture.
In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteria.
Comparison of the 5 microg disc and the Neo-Sensitab for determining the susceptibilities of Staphylococcus aureus isolates to mupirocin.
Evaluation of the impact of non-inpatient i.v. antibiotic treatment for acute infections on the hospital, primary care services and the patient.
Pharmacokinetics of cefuroxime in healthy volunteers: an update.
Fluoroquinolones as treatment for patients with lower respiratory tract infections caused by Streptococcus pneumoniae.
Inoculum preparation for in-vitro susceptibility testing of filamentous fungi.
Concurrent clarithromycin and cyclosporin A treatment.
Escherichia coli O157 interactions with human intestinal Caco-2 cells and the influence of fosfomycin.
Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50.
In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents.
Guidelines for the control of methicillin-resistant Staphylococcus aureus.
Amino acid substitutions at positions 69, 165, 244 and 275 of the PER-1beta-lactamase do not impair enzyme inactivation by clavulanate.
Characterization of the extended-spectrum beta-lactamases and determination of the antibiotic susceptibilities of Klebsiella pneumoniae isolates in Hungary.
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata
